MedPath

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.05%

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.05%

Approved
Approval ID

8738d91c-e668-0a37-e053-2991aa0a663e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 23, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.05%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-1017
Product Classification
G
Generic Name
BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 23, 2019
FDA Product Classification

INGREDIENTS (4)

CLINDAMYCIN PHOSPHATEActive
Quantity: 1 g in 100 g
Code: EH6D7113I8
Classification: ACTIB
NIACINAMIDEActive
Quantity: 2 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB
TRETINOINActive
Quantity: 0.05 g in 100 g
Code: 5688UTC01R
Classification: ACTIB
BENZOYL PEROXIDEActive
Quantity: 5 g in 100 g
Code: W9WZN9A0GM
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.05% - FDA Drug Approval Details